Impact of final oocyte maturation using gonadotropin-releasing hormone agonist triggering and different luteal support protocols on endometrial gene expression

Fecha de publicación:

Autores de IIS La Fe

Participantes ajenos a IIS La Fe

  • Bermejo A
  • Cerrillo M
  • Ruiz-Alonso M
  • Garcia-Velasco JA

Grupos

Abstract

Objective: To use microarray technology to analyze endometrial gene expression after gonadotropin-releasing hormone agonist (GnRH-a) triggering with four different protocols of luteal support in comparison with results obtained after a human chorionic gonadotropin (hCG) trigger. Design: Prospective, randomized, controlled trial. Setting: University-affiliated private assisted-reproduction center. Patient(s): 25 healthy oocyte donors undergoing controlled ovarian stimulation. Intervention(s): On day of final oocyte maturation, randomization to [1] GnRH-agonist triggering and luteal support with oral estradiol (2 mg/8 hours) and vaginal progesterone (200 mg/12 hours), [2] GnRH-a and a daily dose of 150 IU of recombinant LH from oocyte pickup, [3] GnRH-a and a single bolus of 60 mg of recombinant hCG on oocyte pickup, [4] GnRH-a and three doses of 20 mg of recombinant hCG separated by 48 hours, or [5] 250 mg of recombinant hCG for trigger and standard luteal support; with endometrial biopsy samples collected 7 days after triggering. Outcome Measure(s): Gene expression using the Endometrial Receptivity Array ( ERA) and pathway and network analysis of study groups 1-4 compared with controls (group 5). Result(s): The 56 genes in group 1 (25 up-regulated and 31 down-regulated) exhibited altered expression compared with the 36 genes from group 2 (13 up-regulated and 23 down-regulated), 44 from group 3 (28 up-regulated and 16 down-regulated), and 30 (20 up-regulated and 10 down-regulated) from group 4. Conclusion(s): Differences were seen in endometrial gene expression related to the type of ovulation trigger and luteal support. However, gene expression after the GnRH-a trigger and modified luteal support adding LH/hCG activity more closely resembles the pattern seen in the hCG group.

Datos de la publicación

ISSN/ISSNe:
0015-0282, 1556-5653

FERTILITY AND STERILITY  ELSEVIER SCIENCE INC

Tipo:
Article
Páginas:
138-
PubMed:
24182413
Factor de Impacto:
1,983 SCImago
Cuartil:
Q1 SCImago

Citas Recibidas en Web of Science: 16

Documentos

  • No hay documentos

Métricas

Filiaciones mostrar / ocultar

Keywords

  • Endometrial receptivity; gene expression; GnRH agonist; ovarian stimulation

Campos de Estudio

Proyectos y Estudios Clínicos

ESTUDIO DE LA ENFERMEDAD METASTASICA EN EL TEJIDO OVARICO CRIOPRESERVADO DE MUJERES CON CANCER DE MAMA

Investigador Principal: ANTONIO PELLICER MARTÍNEZ

PI08/90483 . INSTITUTO DE SALUD CARLOS III . 2009

CONTRATO POSTDOCTORAL DE INVESTIGACION SARA BORRELL

CD11/00292 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2012

CONTRATO POSTDOCTORAL DE INVESTIGACION SARA BORELL

CD12/00568 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2013

ESTUDIO ALEATORIZADO, DOBLE CIEGO, CONTROLADO CON PLACEBO, PARA EVALUAR SEGURIDAD Y EFICACIA DE ELAGOLIX EN PARTICIPANTES CON DOLOR MODERADO O SEVERO ASOCIADO A ENDOMETRIOSIS.

Investigador Principal: VICENTE PAYÁ AMATE

M12-671

Cita

Compartir